With COVID boosters expected to cost £100 when they go on sale in UK pharmacies, there are concerns about whether this will put people off getting the jab.
A new generation of vaccines and boosters against SARS-CoV-2 may take a page from the anti-influenza playbook, with shots periodically tailored to target the most commonly circulating virus strains.
The COVID-19 pandemic has brought immunology terms that are typically relegated to textbooks into our everyday vernacular. These stories helped us make sense of the ever-evolving science.
It’s too soon to recommend booster shots for younger children. But we can watch what’s happening in the US, where children as young as 12 are receiving theirs.
Booster shots are a common necessity for vaccines to keep working. Recent research shows COVID-19 booster shots are recommended for high-risk individuals — and may benefit the rest of us too.
As boosters are authorized for all three COVID-19 shots available in the US, the ability to swap out vaccine types looks to be a boon to the immune system.
Fault lines between the FDA and CDC regulatory processes have been on full display in the decisions over which groups of Americans should receive the Pfizer booster shot.
An FDA panel has voted against recommending approval of a booster COVID-19 shot for the general population – disappointing some public health officials.
You’ll read lots of different figures on this — six months, eight months, more — and that’s because the research is ongoing. We don’t yet have a concrete answer.
Some countries have started administering third doses of COVID vaccines, or booster shots. But we’re still learning about how long immunity lasts from the first two shots.
A 2015 paper on chicken virus evolution is being taken out of context and used to fuel fears about COVID-19 vaccines. Its lead author aims to clarify the science in hopes of saving lives.
By the time Australia is ready to deliver Novavax, we may well have completed most of the vaccine rollout with AstraZeneca, Pfizer and Moderna. That doesn’t mean Novavax won’t play an important role.